Researchers discover distinct gut bacteria prevalent in people with clinical depression compared to healthy people.
Andrea Macdonald founder of ideaXme interviews Commissioner Virginijus Sinkevičius, European Commissioner for the Environment, Oceans and Fisheries.
The EU Commission @European Commission.
Researchers claim to have reversed ageing in mice. It has long been believed that if we understand the causes of ageing, it may be possible to reverse it. New work on mice shows that it is possible to cure vision loss caused by old age or injury. Researchers think that this effect may depend on rewinding the ‘biological clock’ which marks the age of cells, suggesting that the cells in the eye have been made functionally younger.
Read the paper here: https://www.nature.com/articles/s41586-020-2975-4
Continue reading “Rewinding the biological clock: How to reverse ageing” »
Diseases caused by folded proteins in the body are all over the news every day, like cancer, Alzheimer’s, and COVID-19. And now, a Google model powered by artificial intelligence could map these folded proteins in more detail than ever before, allowing scientists to “unfold” proteins and better explore possible treatments.
➡ Read best-in-class science features and get unlimited access to Pop Mech, starting NOW.
Harvard Medical School scientists have successfully restored vision in mice by turning back the clock on aged eye cells in the retina to recapture youthful gene function.
The team’s work, described Dec. 2 in Nature, represents the first demonstration that it may be possible to safely reprogram complex tissues, such as the nerve cells of the eye, to an earlier age.
In addition to resetting the cells’ aging clock, the researchers successfully reversed vision loss in animals with a condition mimicking human glaucoma, a leading cause of blindness around the world.
For too long, the coronavirus has been allowed to ravage human society. However, now, we have begun deploying our own weapon to fight back against this deadly pestilence- a vaccine. Today, the UK has approved of Pfizer and BioNtech’s coronavirus vaccine.
Discord Link: https://discord.gg/brYJDEr.
Patreon link: https://www.patreon.com/TheFuturistTom.
Please follow our instagram at: https://www.instagram.com/the_futurist_tom.
For business inquires, please contact Technovisionaries1205@gmail.com
MHRA will only become fully independent on 1 January 2021, following Brexit, but U.K. regulations allow it to grant authorizations on an emergency basis. The United Kingdom has bought 40 million doses of the Pfizer/BioNTech vaccine—enough for 20 million people—and health secretary Matt Hancock today announced the first 800,000 doses will be available next week. The rollout will prioritize health workers as well as the elderly and other vulnerable populations, but the Joint Committee on Vaccination and Immunisation has yet to offer its final guidance on the exact priorities.
Russia on 11 August allowed its COVID-19 vaccine, developed by the Gamaleya Research Institute of Epidemiology and Microbiology, to be used on certain groups of people, and China has granted emergency use authorizations (EUAs) for several vaccines and has already vaccinated hundreds of thousands of people with them. A few other countries, including the United Arab Emirates and Bahrain, have issued an EUA for one of the Chinese vaccines, produced by Sinopharm.
The Pfizer vaccine, whose key ingredient is messenger RNA that encodes the spike protein of the pandemic coronavirus, was found to have 95% efficacy, a clinical trial measurement of effectiveness, in a phase III trial in 43,000 people. But it presents logistical challenges for a widescale and rapid rollout, as it requires storage at −70°C. The lesser demands of other vaccines—including a candidate developed by the University of Oxford and AstraZeneca—mean they will likely still play an important role in providing vaccinations for the whole U.K. population—and for global coverage, according to Michael Head, a global health researcher at the University of Southampton, “but, for now, this is wonderful news to wake up to.”
Earlier in the year, many funders agreed to extend deadlines for research projects halted or delayed by the pandemic — but fewer offered extra funding to cover this period. Worryingly, most of the funders we approached still have no concrete plans to provide such additional financial support to postdocs. Many postdocs are not eligible for the government salary subsidies, or furlough schemes, that have been made available to many workers during the pandemic. Expanding access to such schemes is arguably the one intervention that could do the most to ease pressures at this time.
Most funders have no plans to provide postdoctoral researchers with additional pandemic funding. Society will pay a high price if this neglect continues.
